News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Nadia K. Waheed, MD, MPH

Advertisement

Articles by Nadia K. Waheed, MD, MPH

Nadia Waheed, MD, MPH: Transforming retinal disease imaging and clinical trials

ByNadia K. Waheed, MD, MPH,Hattie Hayes,Martin David Harp,Sydney M Crago
October 9th 2025

Ultra-high-resolution OCT advances retinal imaging, enabling detailed visualization of disease progression and potential therapeutic effects in eye conditions.

Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial Design

ByPeter K. Kaiser, MD,Jeffrey Heier, MD,Nadia K. Waheed, MD, MPH
July 28th 2025

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

ByMalvika Arya, BS,A. Yasin Alibhai, MD,Carl B. Rebhun, BA,Xuejing Chen, MD,Elias Reichel, MD ,Caroline R. Baumal, MD ,Andre J. Witkin, MD ,Jay S. Duker, MD ,Nadia K. Waheed, MD, MPH
July 25th 2018

Study aims to identify methodology for least amount of variation, greatest test-retest reliability

Advertisement

Latest Updated Articles

  • Parafoveal retinal vessel density assessment by OCTA in healthy eyes
    Parafoveal retinal vessel density assessment by OCTA in healthy eyes

    Published: July 25th 2018 | Updated:



Advertisement
Advertisement

Trending on Modern Retina

1

Frank Holz, MD, FEBO, FARVO, highlights new treatment developments at EURETINA

2

The Retina TL;DR: Advancing sustained VEGF suppression with EYP-1901 with Jay S. Duker, MD

3

Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy

4

Increasing the knowledge base of GA is key to individualizing patient therapy

  • About
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us